ClariVest Asset Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

ClariVest Asset Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-38,873	Closed	-$1.54M	–	948
2024 Q1	$1.54M	Buy	38,873 +73	+0.2%	+$2.15K	0.16%	192
2023 Q4	$740K	Buy	+38,800	New	+$539K	0.04%	312

ClariVest Asset Management's ALPN Position: Q2 2024 in Review

ClariVest Asset Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 38,873 shares — an estimated $1.54M sold.

ClariVest Asset Management first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $1.54M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

ClariVest Asset Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
ClariVest Asset Management sold 38,873 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $1.54M.
ClariVest Asset Management first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
ClariVest Asset Management's Alpine Immune Sciences Inc position peaked at $1.54M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on ClariVest Asset Management's 13F filing for Q2 2024, filed 7 Aug 2024.